Global Orthopedic Soft Tissue Repair Devices Market 2017-2021 - Product Image

Global Orthopedic Soft Tissue Repair Devices Market 2017-2021

  • ID: 4390816
  • Report
  • Region: Global
  • 114 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AlloSource
  • BioTissue
  • Collagen Solutions
  • Orteq
  • RepliCel
  • TEIJIN
  • MORE
About Orthopedic Soft Tissue Repair Devices

Orthopedic soft tissues are masses of cells that connect, support, or surround bones. Orthopedic soft tissues can include tendons, ligaments, cartilage, fascia, skin, fat, and other fibrous tissues. Accidents, injuries, or degeneration of these tissues with age can result in wear and tear. Tissue damage can be repaired using orthopedic soft tissue repair devices. The repair of orthopedic soft tissues is done either by open surgical procedures or through minimally invasive (MI) procedures, such as arthroscopy.

The treatment of orthopedic soft tissue damage has evolved in the past decade. Reparative and restorative methods have been developed to address the cases of morbidity in young and active individuals. An injury can be focal or diffused. Procedures are being developed not only to alleviate the symptoms associated with soft tissue damage but also to limit the progression of damages into degenerative diseases.

The analysts forecast the global orthopedic soft tissue repair devices market to grow at a CAGR of 10.32% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global orthopedic soft tissue repair devices market for 2017-2021. To calculate the market size, the report considers the sales, value, retrofit, and replacement of the global orthopedic soft tissue repair devices market.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Orthopedic Soft Tissue Repair Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Arthrex
  • Stryker
  • Zimmer Biomet
Other prominent vendors
  • AlloSource
  • RepliCel
  • Orteq
  • CellGenix
  • Collagen Solutions
  • Vericel Corporation
  • BioTissue
  • Geistlich
  • Tornier
  • XTANT MEDICAL
  • TEIJIN
  • Parcus Medical
Market drivers
  • Increasing incidence of road and sports injuries
  • For a full, detailed list, view the full report
Market challenges
  • High cost of and failure rate in clinical trials
  • For a full, detailed list, view the full report
Market trends
  • Strategic partnerships and collaboration activities
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AlloSource
  • BioTissue
  • Collagen Solutions
  • Orteq
  • RepliCel
  • TEIJIN
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Market Overview
  • Cell therapy
  • Tissue scaffold
  • Fixation devices
PART 07: Market segmentation by application
  • Upper extremity
  • Lower extremity
PART 08: Market segmentation by end-user
  • Hospitals and clinics
  • ASCs
  • Physicians' offices
PART 09: Geographical segmentation
  • Orthopedic soft tissue repair devices market in Americas
  • Orthopedic soft tissue repair devices market in EMEA
  • Orthopedic soft tissue repair devices market in APAC
PART 10: Decision Framework

PART 11: Drivers and challenges
  • Market drivers
  • Market challenges
PART 12: Market trends
  • Strategic partnerships and collaboration activities
  • Innovation and discovery of novel products
  • Mobile medical clinics
  • Gene therapy
PART 13: Vendor landscape
  • Competitive landscape
PART 14: Key vendor analysis
  • Zimmer Biomet
  • Arthrex
  • Stryker
  • Key companies to watch
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Market overview: Orthopedic soft tissue repair devices market
Exhibit 02: Global orthopedic soft tissue repair devices market: Impact assessment
Exhibit 03: Scope of global orthopedic soft tissue repair devices in various regions 2016
Exhibit 04: Global orthopedic soft tissue repair devices market 2016-2021 ($ billions)
Exhibit 05: Focus of existing companies and new entrants
Exhibit 06: Opportunity analysis of global orthopedic soft tissue repair devices market
Exhibit 07: Five forces analysis
Exhibit 08: Global orthopedic soft tissue repair devices market revenue by product in 2016-2021 ($ billions)
Exhibit 09: Strategies for companies
Exhibit 10: Market overview of ATI
Exhibit 11: Market overview: Cell therapy
Exhibit 12: Global orthopedic soft tissue repair devices market by cell therapy 2016-2021 ($ billions)
Exhibit 13: Market overview: Tissue scaffold
Exhibit 14: Global orthopedic soft tissue repair devices market by tissue scaffold 2016-2021 ($ billions)
Exhibit 15: Orthopedic fixation devices
Exhibit 16: Market overview: Fixation devices
Exhibit 17: Global orthopedic soft tissue repair devices market by fixation devices 2016-2021 ($ billions)
Exhibit 18: Market share based on application 2016 (%)
Exhibit 19: Pipeline products for global orthopedic soft tissue repair devices by application 2016
Exhibit 20: Global orthopedic soft tissue repair devices market by end-users 2016
Exhibit 21: Buying criteria for end-users in global orthopedic soft tissue repair devices market 2016
Exhibit 22: Buying criteria for end-users: Global orthopedic soft tissue repair devices market 2016
Exhibit 23: Global orthopedic soft tissue repair devices market by geography 2016-2021($ billions)
Exhibit 24: Increasing cases of obesity in US 2010 and 2014 (in millions)
Exhibit 25: Market overview of orthopedic soft tissue repair devices market in Americas
Exhibit 26: Orthopedic soft tissue repair devices market in Americas 2016-2021 ($ billions)
Exhibit 27: Orthopedic soft tissue repair devices market in Americas: Country-specific market analysis
Exhibit 28: Key takeaway for US
Exhibit 29: Total % of aging population in 2014
Exhibit 30: Market overview of orthopedic soft tissue repair devices market in EMEA
Exhibit 31: Orthopedic soft tissue repair devices market in EMEA 2016-2021 ($ billions)
Exhibit 32: Orthopedic soft tissue repair devices market in EMEA: Country-specific market analysis
Exhibit 33: Key takeaway for UK
Exhibit 34: Market overview of orthopedic soft tissue repair devices market in APAC
Exhibit 35: Orthopedic soft tissue repair devices market in APAC 2016-2021 ($ billions)
Exhibit 36: Orthopedic soft tissue repair devices market in APAC: Country-specific market analysis
Exhibit 37: Key takeaway in India
Exhibit 38: Severity of road accidents per 100 accidents in 2014 and 2015
Exhibit 39: The number of inpatients and outpatients for joint procedures between 2006-2016 in US
Exhibit 40: Number of hospital M&A in US
Exhibit 41: Partnerships for marketing orthopedic soft tissue repair products
Exhibit 42: Partnership and collaboration activities
Exhibit 43: Novel products for cartilage repair
Exhibit 44: Competitive structure analysis of orthopedic soft tissue repair devices market
Exhibit 45: Competitive strategy for manufacturing companies
Exhibit 46: Competitive landscape analysis of companies
Exhibit 47: Business strategies for companies in global orthopedic soft tissue repair devices market
Exhibit 48: Zimmer Biomet: key highlights
Exhibit 49: Zimmer Biomet: Strength Assessment
Exhibit 50: Zimmer Biomet: strategy assessment
Exhibit 51: Zimmer Biomet: Opportunity Assessment
Exhibit 52: Arthrex: Key highlights
Exhibit 53: Arthrex: strength assessment
Exhibit 54: Arthrex: Strategy Assessment
Exhibit 55: Arthrex: Opportunity assessment
Exhibit 56: Stryker: Key highlights
Exhibit 57: Stryker: Strength assessment
Exhibit 58: Stryker: Strategy Assessment
Exhibit 59: Stryker: Opportunity Assessment
Exhibit 60: Key companies to watch: Global orthopedic soft tissue repair devices market
Exhibit 61: Other prominent vendors: Global orthopedic soft tissue repair devices market
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AlloSource
  • BioTissue
  • Collagen Solutions
  • Orteq
  • RepliCel
  • TEIJIN
  • MORE
New Report Released: - Global Orthopedic Soft Tissue Repair Devices Market 2017-2021

The author of the report recognizes the following companies as the key players in the global orthopedic soft tissue repair devices market: Arthrex, Stryker, and Zimmer Biomet

Other Prominent Vendors in the market are: AlloSource, RepliCel, Orteq, CellGenix, Collagen Solutions, Vericel Corporation, BioTissue, Geistlich, Tornier, XTANT MEDICAL, TEIJIN, and Parcus Medical.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is Strategic partnerships and collaboration activities. The orthopedic soft tissue repair devices market is characterized by the presence of many vendors, leading to intense competition. Hence, it becomes necessary for vendors to make strategic partnerships with medical universities and other manufacturing companies for product development and thereby, maintain their market shares.”

According to the report, one of the major drivers for this market is Increasing incidence of road and sports injuries. Globally, road injuries are increasing. Such injuries can damage soft tissues. According to the CDC in 2016, each year, an average of 20-30 million people is injured and disabled by road accidents. The cost of road injuries was estimated to be $518 billion per year. It also stated that the US, New Zealand, Canada, France, Japan, and Germany have seen a large number injuries and deaths due to road injuries.

Further, the report states that one of the major factors hindering the growth of this market is High cost of and failure rate in clinical trials. Most vendors conduct clinical trials in developed countries such as the US, the UK, Germany, France, Japan, Singapore, and South Korea. The cost of clinical trials and product launches can be very expensive in these regions. Most of the small vendors or start-up biotech companies seek government or private funding, which may be limited. The estimated cost of orthopedic soft tissue repair products such as cell therapy-based products from clinical development stage to commercialization can cost up to $1.5 billion to the company.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Arthrex
  • Stryker
  • Zimmer Biomet
  • AlloSource
  • RepliCel
  • Orteq
  • CellGenix
  • Collagen Solutions
  • Vericel Corporation
  • BioTissue
  • Geistlich
  • Tornier
  • XTANT MEDICAL
  • TEIJIN
  • Parcus Medical
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll